Cutera

Cutera, Inc. engages in the provision of laser and energy-based aesthetic systems for practitioners. It operates through the following segments: United States, Japan, Asia excluding Japan, Europe, and Rest of the World. Its products include enlighten, excel HR, excel V+, secret Pro, Juliet, secret RF, and xeo. The company was founded by David A. Gollnick in August 1998 and is headquartered in Brisbane, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cutera reports strong 2022 performance with focus on AviClear growth

Cutera's performance in 2022 showcased resilience and growth potential, driven by the successful AviClear launch. While facing revenue challenges in Q4 2022, the company is optimistic about achieving cash flow breakeven by Q4 2023. With a bullish outlook for 2023, Cutera aims to leverage its core business strength and accelerate AviClear sales.

Cutera reports Q1 revenue dip, focuses on AviClear growth

Cutera faces challenges in North American sales but sees growth opportunities internationally and with AviClear devices.
Financials show a loss in adjusted EBITDA and decreased cash, but the company is focused on improving execution and driving utilization rates.
Retention incentives have been effective, and steps are being taken to enhance performance and return to sustainable growth.

Cutera reports Q2 revenue decline, focuses on AviClear performance

Cutera reported Q2 2023 revenue of $61.2 million, down 5% YoY, with an adjusted EBITDA loss of $11.6 million. The company is focusing on AviClear performance, quality control, and core business growth.
Challenges include declining core capital business, operational issues, and macroeconomic challenges. Opportunities lie in optimizing AviClear utilization, enhancing reliability, and introducing new products for growth.
Cutera's commitment to addressing challenges, enhancing service levels, and executing a strategic plan for sustainable growth is evident. The organization is resilient in the face of macroeconomic pressures and is adapting its strategies for success.
Retention bonuses, successful employee retention, and efforts to improve quality control measures demonstrate Cutera's internal strengths. The company's strategic approach to product lines and growth showcases a positive outlook for the future.

Cutera reports Q3 revenue decline, focuses on cost reduction

Cutera faces revenue decline and operational challenges in Q3 2023, impacting full-year guidance. Plans for cost reduction, growth strategies, and personnel restructuring in progress. Positive outlook for achieving financial goals with confidence.

Cutera reports Q4 revenue growth, focuses on AviClear expansion

Cutera's Q4 performance reflects resilience with better-than-anticipated revenue and stable AviClear revenue.
Focus on operational excellence, global franchise building, and customer support positions Cutera for long-term success.
Efforts to address challenges like inventory management and customer adoption of new business models are crucial for growth.

Cutera reports mixed Q1 results, focuses on AviClear growth

Cutera's Q1 performance showed a revenue decline but growth in AviClear revenue, with a focus on operational excellence and building a strong AviClear franchise. The company faces challenges with declining customer site volumes and an uncertain timeline for patient demand. However, opportunities exist in international expansion, R&D innovation, and addressing future market needs.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Luminar Technologies

Sunnova Energy International Inc

Short sellers in Lumimar Technologies (LAZR), Sunnova Energy (NOVA), and Cutera (CUTR) are thriving as their stocks have plunged. Luminar's shares have plunged by almost 50% this year and by more than 96% from its all-time high.

Shorts thrive as Luminar, Sunnova, and Cutera stock prices dive

Cutera, Inc. (CUTR) Q4 2023 Earnings Call Transcript

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today reported financial results for the fourth quarter and full-year ended December 31, 2023. Consolidated revenue for the fourth quarter of 2023 of $49.5 million Full-year 2023 revenue of $212.4 million, ahead of guidance of approximately $205 million Cash and marketable securities of $143.6 million as of December 31, 2023, ahead of guidance of.

Cutera Announces Fourth Quarter and Full-Year 2023 Financial Results Along with 2024 Outlook

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023 after the market close on Thursday, March 21, 2024. The Company intends to file its Quarterly Report on Form 10-Q for the third quarter ended September 30, 2023 and restated Quarterly Reports for the first and second quarters of 2023.

Cutera to Announce Fourth Quarter and Full-Year 2023 Results on March 21, 2024

IRIDEX

MicroVision

The Zacks Laser Systems and Components industry participants like MicroVision (MVIS), Cutera (CUTR) and IRIDEX Corporation (IRIX) gain from solid demand for emerging applications like autonomous driving, IoT, 5G and healthcare amid challenging macroeconomic conditions.

3 Laser Systems Stocks to Watch in a Challenging Industry

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced the international limited commercial release of AviClear, the first energy-based device FDA-cleared for the long-term treatment of mild, moderate, and severe acne. AviClear received an enthusiastic reception at this year's International Master Course on Aging Science (IMCAS) conference in Paris, France, held February 1-3. AviClear is a 1726nm laser, which targets.

Cutera Announces the International Limited Commercial Release of AviClear® at IMCAS World Congress 2024

Commercial Metals

Cenovus Energy

CVE, CMC and CUTR have been added to the Zacks Rank #5 (Strong Sell) List on January 23, 2023.

New Strong Sell Stocks for January 23rd

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced certain preliminary, unaudited financial results for the year ended December 31, 2023. These results are unaudited, subject to the completion of the Company's year-end financial reporting processes, reviews, audit, and potential adjustments that might result. Based on these preliminary results, the Company expects: Revenue in the.

Cutera, Inc. Announces Preliminary Unaudited Financial Results for Full-Year 2023

Curaleaf Holdings, Inc.

DuPont de Nemours

Alphabet

Green Thumb Industries Inc.

International Flavors & Fragrances

Mercury Systems

Microsoft

AdvisorShares Pure US Cannabis ETF

NVIDIA

Pfizer

Pioneer Natural Resources

Trulieve Cannabis Corp.

Tesla

Exxon Mobil

In an annual year-end ritual, investors have dumped many of their stock losers to offset taxable gains. This so-called “tax loss selling” can create buying opportunities in promising names.

Tax-loss selling makes these stocks in cannabis, pharma, energy and industrials worth buying

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that Stephana Patton, who joined Cutera on November 13, 2023, as the Chief Legal Officer will receive a grant of inducement awards. The inducement awards consisted of stock options to purchase 30,000 of common stock, restricted stock units (RSUs) settleable in 25,000 shares of common stock, and performance stock units (PSUs) settl.

Cutera, Inc. Reports Inducement Grants as permitted by the Nasdaq Listing Rules

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, announced today that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on November 15, 2023 indicating that the Company is not currently in compliance with Nasdaq's Listing Rules (the “Listing Rules”) due to the Company's inability to timely file its Form 10-Q for the period e.

Cutera, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 10-Q

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, is pleased to announce the appointment of Stephana Patton, Ph.D., J.D. as Chief Legal Officer, effective November 13, 2023. Dr. Patton will report directly to Taylor Harris, Cutera's Chief Executive Officer, and will be responsible for leading the legal, compliance, intellectual property and human resources functions. Dr. Patton brings over two d.

Cutera Appoints Stephana Patton as Chief Legal Officer

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that Taylor Harris, Chief Executive Office, and Greg Barker, Vice President of Corporate FP&A and Investor Relations, will participate in Fireside Chats at the following upcoming investor conferences: Stifel 2023 Healthcare Conference, 2:25pm ET on Wednesday, November 15, 2023, at the Lotte New York Palace Hotel, New York, NY.

Cutera, Inc. to Participate in Upcoming Investor Conferences

Cutera, Inc. (NASDAQ:CUTR ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Greg Barker - VP, Finance & IR Taylor Harris - CEO Stuart Drummond - Interim CFO Conference Call Participants George Sellers - Stephens Inc. Jonathan Block - Stifel Margaret Kaczor - William Blair Matthew O'Brien - Piper Sandler Operator Welcome to the Cutera Inc. Third Quarter 2023 Business Update Conference Call. As a reminder, all participants are in listen-only mode and the conference is being recorded.

Cutera, Inc. (CUTR) Q3 2023 Earnings Call Transcript

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today provided preliminary financial results for the third quarter ended September 30, 2023, as well as recent business updates. Some Company highlights: Consolidated revenue for the third quarter of 2023 of $46.5 million, a decrease of 26% compared to the third quarter of 2022 Cash and marketable securities of $179.5 million as of the end of the.

Cutera Provides Third Quarter 2023 Business Update

Cutera (CUTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Cutera (CUTR) to Report a Decline in Earnings: What to Look Out for

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the third quarter of 2023 after the market close on Wednesday, November 8, 2023. The Company's management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m. ET) that same day. To join the conference call, dial 1-800-319-4610 (domestic) or +1.

Cutera, Inc. to Announce Third Quarter Results on November 8, 2023

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that on October 3, 2023 the Compensation Committee of Cutera's Board of Directors approved the grant of inducement awards to Brent Hauser, who joined Cutera on October 2, 2023, as the President, International. The inducement awards consisted of restricted stock units (RSUs) settleable in 27,358 shares of common stock, and two gran.

Cutera Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

Omega Therapeutics

Revolution Medicines

Volitionrx Limited

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Top 4 Health Care Stocks That Are Preparing To Pump This Quarter - Omega Therapeutics (NASDAQ:OMGA), Cutera (NASDAQ:CUTR)

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, is pleased to announce the appointment of Brent Hauser as President, International, effective October 2, 2023. Mr. Hauser will report directly to Taylor Harris, Cutera's Chief Executive Officer, and will be responsible for commercial performance in existing international markets, expansion into new geographies, and the international launch of Avi.

Cutera, Inc. Appoints Brent Hauser as President, International

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (Nasdaq: CUTR) a global leader in aesthetic and dermatology solutions, today announces the launch of Secret DUO, an innovative skin resurfacing and revitalization platform that utilizes dual non-ablative fractional technologies. Each modality can be used individually or in combination to target a wide range of aesthetic indications. Optimized to treat varying layers of the skin, Secret DUO is equipped with a radio frequency microneedling (RFMN) ha.

Cutera Announces the Launch of New Skin Resurfacing and Revitalization Platform Secret DUO®

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that on August 17,2023 the Compensation Committee of Cutera's Board of Directors approved the grant of inducement awards to Jeffrey Jones, who joined Cutera on August 28, 2023, as the Chief Operating Officer. The inducement awards consisted of stock options to purchase 31,256 of common stock, restricted stock units (RSUs) settleab.

Cutera Reports Inducement Grants as permitted by the Nasdaq Listing Rules

NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Cutera, Inc. (NASDAQ: CUTR) on behalf of long-term stockholders following a class action complaint that was filed against Cutera on May 24, 2023 with a Class Period from February 17, 2021, to May 9, 2023. Our investigation concerns whether the board of directors of Cutera have breached their fiduciary duties to the company. Recently a class a.

CUTERA ALERT: Bragar Eagel & Squire, P.C. is Investigating Cutera, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, is pleased to announce the appointment of Jeff Jones as Chief Operating Officer, effective August 28, 2023. This move underscores Cutera's commitment to delivering world-class product quality, reliability, and service to customers. Mr. Jones will report directly to Taylor Harris, Cutera's Chief Executive Officer, and will be responsible for end-t.

Cutera, Inc. Appoints Jeff Jones as Chief Operating Officer

Cutera, Inc. (NASDAQ:CUTR ) Q2 2023 Earnings Call Transcript August 8, 2023 4:30 PM ET Company Participants Sheila Hopkins - Former Interim Chief Executive Officer Stuart Drummond - Interim Chief Financial Officer Taylor Harris - Chief Executive Officer Greg Barker - Vice President of Financial Planning and Investor Relations Conference Call Participants George Sellers - Stephens Inc. Jon Block - Stifel Anthony Vendetti - Maxim Group Margaret Kaczor - William Blair Operator Thank you for standing by. This is the conference operator.

News for Cutera Stock (CUTR)